Flonase and Facial paralysis - a phase IV clinical study of FDA data

Summary:

Facial paralysis is reported as a side effect among people who take Flonase (fluticasone propionate), especially for people who are female, 60+ old, also take Biotin, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Facial paralysis when taking Flonase. It is created by eHealthMe based on reports of 73,331 people who have side effects when taking Flonase from the FDA, and is updated regularly.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

What is Facial paralysis?

Facial paralysis (loss of function of face muscle) is found to be associated with 664 drugs and 1,146 conditions by eHealthMe. Check the latest studies of Facial paralysis.

On Jul, 06, 2026

73,331 people reported to have side effects when taking Flonase.
Among them, 36 people (0.05%) have Facial paralysis.

Among these 36 people:

What is the gender of people who have Facial paralysis when taking Flonase? *

female: 68.57 %
male: 31.43 %

What is the age of people who have Facial paralysis when taking Flonase? *

What are other drugs people take besides Flonase? *

What are other side effects people have besides Facial paralysis? *

Weakness: 11 people, 30.56%
Speech Impairment (Adult) (inability to speak (adult)): 11 people, 30.56%
Dyspnea (difficult or laboured breathing): 10 people, 27.78%
Fall: 10 people, 27.78%
Headache (pain in head): 8 people, 22.22%
Herpes Zoster: 7 people, 19.44%
Fatigue (feeling of tiredness): 7 people, 19.44%
Stress And Anxiety: 6 people, 16.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 16.67%
Swallowing Difficulty: 6 people, 16.67%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 19.44%
High Blood Pressure: 6 people, 16.67%
Allergic Sinusitis: 6 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 16.67%
Osteoporosis (bones weak and more likely to break): 6 people, 16.67%
Neuropathy Peripheral (surface nerve damage): 5 people, 13.89%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 11.11%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 11.11%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 11.11%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase and have Facial paralysis?

- Check whether Facial paralysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flonase:

Flonase (75,441 reports)

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Facial paralysis:

Facial paralysis (664 drugs)

Browse all the conditions that are associated with Facial paralysis:

Facial paralysis (1,146 conditions)

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate (the active ingredients of Flonase) and Flonase (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.